Finally, M2d describes a pro-angiogenic and tumor-promoting phenotype that is activated by adenosine receptors or TLR antagonists and expresses vascular endothelial growth factor (VEGF) and IL-10 (34–36). Here, VEGFA is linked to neoplasm.